INSIDER · CIK 1708172
Kasinger James R.
General Counsel and Secretary at CRISPR Therapeutics AG (CRSP)
↗6 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$797KSold on the market
1Companies
Oct 15, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 15, 202617:35 | Oct 14, 2026 | CRSPCRISPR Therapeutics AG | General Counsel and Secretary | S · Sell | $49.26 | −1,040 | 95,857 | -1% | −$51K | ||
| Oct 15, 202617:35 | Oct 13, 2026 | CRSPCRISPR Therapeutics AG | General Counsel and Secretary | M · Exercise | — | +2,113 | 96,897 | +2% | — | ||
| Oct 8, 202617:35 | Oct 6, 2026 | CRSPCRISPR Therapeutics AG | General Counsel and Secretary | S · Sell10b5-1 | $60.04 | −1,990 | 94,784 | -2% | −$119K | ||
| Oct 8, 202617:35 | Oct 6, 2026 | CRSPCRISPR Therapeutics AG | General Counsel and Secretary | M · Exercise10b5-1 | $13.62 | +1,990 | 96,774 | +2% | $27K | ||
| Sep 24, 202617:35 | Sep 22, 2026 | CRSPCRISPR Therapeutics AG | General Counsel and Secretary | S · Sell10b5-1 | $60.24 | −10,400 | 94,784 | -10% | −$626K | ||
| Sep 24, 202617:35 | Sep 22, 2026 | CRSPCRISPR Therapeutics AG | General Counsel and Secretary | M · Exercise10b5-1 | $13.62 | +10,400 | 105,184 | +11% | $142K |